5 Best 52-Week Low Stocks To Buy Now

2. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 75

On January 31, Pfizer Inc. (NYSE:PFE) announced earnings for the fourth quarter of fiscal 2022. The company generated a revenue of $24.29 billion and reported an EPS of $1.14, outperforming EPS estimates by $0.10. As of March 14, the stock has fallen by 23.67% over the past 12 months and is trading at a PE multiple of 7x.

On March 6, Jefferies analyst Akash Tewari took coverage of Pfizer Inc. (NYSE:PFE) with a Hold rating and a $43 price target. Pfizer Inc. (NYSE:PFE) is placed second on our list of the best 52-week low stocks to buy now according to hedge funds and analysts.

At the close of the fourth quarter of 2022, 75 hedge funds were long Pfizer Inc. (NYSE:PFE) and disclosed positions worth 2.50 billion in the company. This is compared to 77 hedge funds in the previous quarter with stakes worth $2.44 billion. As of December 31, AQR Capital Management is the top stockholder in the company and has a stake worth $502.7 million.

Follow Pfizer Inc (NYSE:PFE)